Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Liver Metastasis Colon Cancer × FOLFOXIRI protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 9 Colorectal Neoplasms 9 Colonic Neoplasms 4 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Liver Metastasis Colon Cancer 1 Carcinoma, Neuroendocrine 1

Interventions

Bevacizumab 2 regorafenib 1 Radiofrequency Ablation 1 PSMA-BCH 1 Oxaliplatin 1 IFL protocol 1 FOLFOXIRI protocol 1 Electroporation 1 Cetuximab 1 CPG-oligonucleotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04832776 2021-04-06

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

Fudan University

Phase 2 Unknown

Gastrointestinal

Liver Metastasis Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡